Biotech Leaders Sign Letter Condemning Trump’s Travel Ban
Wednesday, February 8, 2017
Posted by: Kate Oesterle
Xconomy National — The blowback from U.S. business leaders to President Trump’s travel ban continues—today from a throng of biotech executives. This morning, 165 U.S. biotech leaders have signed a letter voicing “deep concern and opposition” to the order, which bars entry to the U.S. to refugees and immigrants from seven Muslim-majority countries.
The Jan. 27 order placed a 90-day ban on immigrants from Iraq, Iran, Syria, Sudan, Somalia, Libya, and Yemen. It also barred Syrian refugees indefinitely and other refugees for 120 days. The order is currently on temporary hold thanks to the ruling of a federal judge in Seattle, though that could be lifted after an appeals court hearing later today. The case could eventually make its way to the U.S. Supreme Court.
The travel ban has faced mounting vocal opposition from U.S. business leaders. Just yesterday, for instance, a group of major tech companies such as Apple, Google, Tesla, and Microsoft co-signed a “friend of the court” brief with the 9th U.S. Circuit Court of Appeals in San Francisco saying that the order will cause “significant harm on American businesses.”
Read full article here.